Delivery Order SPE2DR25D2108-SPE2DR26F6RD5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,475.06 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets (30-count supply) on November 25, 2025, with an ultimate completion date of November 26, 2025. The contract employs firm fixed-price pricing and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count), with a ceiling value of $9,953.41. This delivery order is a firm fixed price contract with no set-aside designation, reflecting competitive award status. The contract is scheduled for ultimate completion by August 1, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) on December 3, 2025, with a ceiling value of $2,201.74 and firm fixed pricing. This competitive award, with no set-aside designation, represents a single delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $4,574.72 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 13, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $2,724.06. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,258.85 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). The contract, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $1,379.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count). The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of December 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count) valued at $4,197.60. The contract was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents a competitive award to AmerisourceBergen's corporate office, with the place of performance located in Conshohocken,...
- The Defense Logistics Agency awarded a $7,859.79 delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in quantities of 30 units. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of November 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count), with a ceiling value of $2,158.79. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by November 5, 2025, with performance taking place at AmerisourceBergen's Conshohocken,...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6RD5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets (30-count) on November 26, 2025, with a ceiling value of $2,078.58. This firm fixed price delivery order, with an ultimate completion date of November 28, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current delivery order for this antihypertensive medication falls within the scope of AmerisourceBergen's established pharmaceutical distribution capabilities to federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/25/25 |